十二步计划与团契的分子神经生物学:连接康复的点点滴滴

Kenneth Blum, Benjamin Thompson, Zsolt Demotrovics, John Femino, John Giordano, Marlene Oscar-Berman, Scott Teitelbaum, David E Smith, A Kennison Roy, Gozde Agan, James Fratantonio, Rajendra D Badgaiyan, Mark S Gold
{"title":"十二步计划与团契的分子神经生物学:连接康复的点点滴滴","authors":"Kenneth Blum, Benjamin Thompson, Zsolt Demotrovics, John Femino, John Giordano, Marlene Oscar-Berman, Scott Teitelbaum, David E Smith, A Kennison Roy, Gozde Agan, James Fratantonio, Rajendra D Badgaiyan, Mark S Gold","doi":"10.17756/jrds.2015-008","DOIUrl":null,"url":null,"abstract":"<p><p>There are some who suggest that alcoholism and drug abuse are not diseases at all and that they are not consequences of a brain disorder as espoused recently by the American Society of Addiction Medicine (ASAM). Some would argue that addicts can quit on their own and moderate their alcohol and drug intake. When they present to a treatment program or enter the 12 Step Program & Fellowship, many addicts finally achieve complete abstinence. However, when controlled drinking fails, there may be successful alternatives that fit particular groups of individuals. In this expert opinion, we attempt to identify personal differences in recovery, by clarifying the molecular neurobiological basis of each step of the 12 Step Program. We explore the impact that the molecular neurobiological basis of the 12 steps can have on Reward Deficiency Syndrome (RDS) despite addiction risk gene polymorphisms. This exploration has already been accomplished in part by Blum and others in a 2013 Springer Neuroscience Brief. The purpose of this expert opinion is to briefly, outline the molecular neurobiological and genetic links, especially as they relate to the role of epigenetic changes that are possible in individuals who regularly attend AA meetings. It begs the question as to whether \"12 steps programs and fellowship\" does induce neuroplasticity and continued dopamine D2 receptor proliferation despite carrying hypodopaminergic type polymorphisms such as DRD2 A1 allele. \"Like-minded\" doctors of ASAM are cognizant that patients in treatment without the \"<i>psycho-social-spiritual trio</i>,\" may not be obtaining the important benefits afforded by adopting 12-step doctrines. Are we better off with coupling medical assisted treatment (MAT) that favors combining dopamine agonist modalities (DAM) as possible histone-deacetylase activators with the 12 steps followed by a program that embraces either one or the other? While there are many unanswered questions, at least we have reached a time when \"science meets recovery,\" and in doing so, can further redeem joy in recovery.</p>","PeriodicalId":90909,"journal":{"name":"Journal of reward deficiency syndrome","volume":"1 1","pages":"46-64"},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545669/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.\",\"authors\":\"Kenneth Blum, Benjamin Thompson, Zsolt Demotrovics, John Femino, John Giordano, Marlene Oscar-Berman, Scott Teitelbaum, David E Smith, A Kennison Roy, Gozde Agan, James Fratantonio, Rajendra D Badgaiyan, Mark S Gold\",\"doi\":\"10.17756/jrds.2015-008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>There are some who suggest that alcoholism and drug abuse are not diseases at all and that they are not consequences of a brain disorder as espoused recently by the American Society of Addiction Medicine (ASAM). Some would argue that addicts can quit on their own and moderate their alcohol and drug intake. When they present to a treatment program or enter the 12 Step Program & Fellowship, many addicts finally achieve complete abstinence. However, when controlled drinking fails, there may be successful alternatives that fit particular groups of individuals. In this expert opinion, we attempt to identify personal differences in recovery, by clarifying the molecular neurobiological basis of each step of the 12 Step Program. We explore the impact that the molecular neurobiological basis of the 12 steps can have on Reward Deficiency Syndrome (RDS) despite addiction risk gene polymorphisms. This exploration has already been accomplished in part by Blum and others in a 2013 Springer Neuroscience Brief. The purpose of this expert opinion is to briefly, outline the molecular neurobiological and genetic links, especially as they relate to the role of epigenetic changes that are possible in individuals who regularly attend AA meetings. It begs the question as to whether \\\"12 steps programs and fellowship\\\" does induce neuroplasticity and continued dopamine D2 receptor proliferation despite carrying hypodopaminergic type polymorphisms such as DRD2 A1 allele. \\\"Like-minded\\\" doctors of ASAM are cognizant that patients in treatment without the \\\"<i>psycho-social-spiritual trio</i>,\\\" may not be obtaining the important benefits afforded by adopting 12-step doctrines. Are we better off with coupling medical assisted treatment (MAT) that favors combining dopamine agonist modalities (DAM) as possible histone-deacetylase activators with the 12 steps followed by a program that embraces either one or the other? While there are many unanswered questions, at least we have reached a time when \\\"science meets recovery,\\\" and in doing so, can further redeem joy in recovery.</p>\",\"PeriodicalId\":90909,\"journal\":{\"name\":\"Journal of reward deficiency syndrome\",\"volume\":\"1 1\",\"pages\":\"46-64\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545669/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of reward deficiency syndrome\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17756/jrds.2015-008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of reward deficiency syndrome","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17756/jrds.2015-008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

有些人认为,酗酒和吸毒根本不是疾病,也不是美国成瘾医学协会(ASAM)最近所主张的大脑失调的后果。有些人认为,瘾君子可以自己戒酒,并控制酒精和毒品的摄入量。当他们参加治疗计划或加入 12 步戒毒计划和联谊会时,许多瘾君子最终实现了完全戒断。然而,当控制饮酒失败时,可能会有适合特定人群的成功替代方法。在这份专家意见书中,我们试图通过阐明 12 步疗法每一步的分子神经生物学基础,找出戒毒过程中的个人差异。尽管存在成瘾风险基因多态性,我们仍将探索 12 步疗法的分子神经生物学基础对奖赏缺失综合症(RDS)的影响。布卢姆等人已经在 2013 年的 Springer Neuroscience Brief 中完成了部分探索。本专家意见的目的是简要概述分子神经生物学和遗传学之间的联系,尤其是与经常参加戒酒互助会的人可能发生的表观遗传变化有关的联系。这就引出了一个问题,即 "12 步计划和团契 "是否会诱导神经可塑性,并在携带低多巴胺能型多态性(如 DRD2 A1 等位基因)的情况下继续诱导多巴胺 D2 受体增殖。ASAM的 "志同道合 "的医生们认识到,没有接受 "心理-社会-精神三合一 "治疗的患者可能无法获得采用12步疗法所带来的重要益处。医学辅助治疗(MAT)倾向于将多巴胺激动剂模式(DAM)作为可能的组蛋白-去乙酰化酶激活剂与 12 步疗法结合起来,然后再实施一项包含其中一种或另一种疗法的计划,这样做对我们是否更好?虽然还有许多问题没有答案,但至少我们已经到了 "科学与康复 "相结合的时候,这样做可以进一步挽回康复中的快乐。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.

The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.

The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.

The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.

There are some who suggest that alcoholism and drug abuse are not diseases at all and that they are not consequences of a brain disorder as espoused recently by the American Society of Addiction Medicine (ASAM). Some would argue that addicts can quit on their own and moderate their alcohol and drug intake. When they present to a treatment program or enter the 12 Step Program & Fellowship, many addicts finally achieve complete abstinence. However, when controlled drinking fails, there may be successful alternatives that fit particular groups of individuals. In this expert opinion, we attempt to identify personal differences in recovery, by clarifying the molecular neurobiological basis of each step of the 12 Step Program. We explore the impact that the molecular neurobiological basis of the 12 steps can have on Reward Deficiency Syndrome (RDS) despite addiction risk gene polymorphisms. This exploration has already been accomplished in part by Blum and others in a 2013 Springer Neuroscience Brief. The purpose of this expert opinion is to briefly, outline the molecular neurobiological and genetic links, especially as they relate to the role of epigenetic changes that are possible in individuals who regularly attend AA meetings. It begs the question as to whether "12 steps programs and fellowship" does induce neuroplasticity and continued dopamine D2 receptor proliferation despite carrying hypodopaminergic type polymorphisms such as DRD2 A1 allele. "Like-minded" doctors of ASAM are cognizant that patients in treatment without the "psycho-social-spiritual trio," may not be obtaining the important benefits afforded by adopting 12-step doctrines. Are we better off with coupling medical assisted treatment (MAT) that favors combining dopamine agonist modalities (DAM) as possible histone-deacetylase activators with the 12 steps followed by a program that embraces either one or the other? While there are many unanswered questions, at least we have reached a time when "science meets recovery," and in doing so, can further redeem joy in recovery.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信